80 results match your criteria: "Koga General Hospital.[Affiliation]"
Anticancer Res
August 2021
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Background/aim: Direct-acting antiviral (DAA) therapies for patients with hepatitis C virus (HCV) infection deliver higher cure rates and lower frequencies of adverse events than existing therapies, though DAA treatment costs $45,000-64,000 in Japan. The prognosis of patients who require new long-term care insurance (LTCI) certification is inferior to that of patients who do not. Here, we clarify the factors associated with new LTCI certification in elderly patients with HCV infection who undergo DAA therapy.
View Article and Find Full Text PDFIntern Med
January 2022
Department of Internal Medicine, Koga General Hospital, Japan.
Hepatic cysts usually do not cause symptoms and may be detected incidentally on abdominal imaging. However, a giant hepatic cyst can rarely compress the inferior vena cava, right lung, and spine, leading to edema of lower extremities and scoliosis.
View Article and Find Full Text PDFCirc Rep
July 2020
Department of Internal Medicine, Koga General Hospital Miyazaki Japan.
Background: The clinical characteristics of IgG4-related sclerosing cholangitis (IgG4-SC) especially without autoimmune pancreatitis (AIP) have not been investigated in a large cohort.
Aims: To clarify the clinical characteristics of IgG4-SC and IgG4-SC without AIP.
Methods: We retrospectively reviewed imaging, serology, other organ involvement (OOI) and histology of 872 patients with IgG4-SC who participated in a Japanese nationwide survey in 2019, and compared these items between IgG4-SC with and without AIP.
J Clin Med
December 2020
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
The prognosis of multiple myeloma (MM) has improved with the introduction of novel agents. These data are largely derived from clinical trials and might not reflect real-world patient outcomes accurately. We surveyed real-world data from 284 patients newly diagnosed with MM between 2010 and 2018 in Miyazaki Prefecture.
View Article and Find Full Text PDFEur J Haematol
March 2021
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Objective And Method: Adult T-cell leukemia/lymphoma (ATL) is an aggressive peripheral T-cell lymphoma with poor prognosis. We retrospectively reviewed the medical records of 312 patients with aggressive ATL and analyzed the effect of chemotherapy dose intensity on prognosis in clinical practice.
Result: As first-line therapy, 62 patients underwent best supportive care (BSC) or single-agent chemotherapy, and 235 underwent intensive chemotherapy.
Thromb Haemost
October 2020
Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
The effects of antithrombotic therapy on deep vein thrombosis (DVT) can be affected by thrombus age, which cannot be reliably determined by noninvasive imaging modalities. We investigated whether magnetic resonance (MR) diffusion-weighted imaging (DWI) can localize and determine the age of venous thrombus in patients with DVT, animal models, and human blood in vitro. Signal intensity (SI) on DWI and the apparent diffusion coefficient (ADC) of thrombi were assessed in eight patients with DVT using a 1.
View Article and Find Full Text PDFIntern Med
November 2020
Department of Orthopaedic Surgery, Koga General Hospital, Japan.
CMAJ
November 2019
Department of Internal Medicine, Koga General Hospital, Miyazaki, Japan
Radiol Case Rep
September 2019
Department of Internal Medicine, Koga General Hospital, Miyazaki, Japan.
Immunoglobulin (IgG) 4-related disease is a systemic inflammatory disease, and it affects vascular system as aortitis, periaortitis, or aneurysm. However, due to a lack of serum biomarker on aortic damage and the multiorgan involvement, it is difficult to assess aortic inflammatory activity of IgG4-related disease. We described a case of IgG4-related pancreatitis and aortitis, which was visualized with magnetic resonance merged image of diffusion weighted and T weighted images.
View Article and Find Full Text PDFThorax
July 2019
Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Cardiovasc Pathol
July 2019
Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Coronary high-signal-intensity plaques (HIPs) detected by T-weighted magnetic resonance imaging are associated with future cardiovascular events. This study aimed to identify pathological findings reflecting HIPs in coronary arteries obtained from autopsy cases. Formalin-fixed hearts were imaged with noncontrast T-weighted imaging with a 1.
View Article and Find Full Text PDFJ Med Case Rep
January 2019
Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital, Jaese Foundation for Cancer Research, Tokyo, Japan.
Background: Panitumumab is the first human combinatorial antibody for the treatment of metastatic colorectal carcinoma. Dermatologic toxicity of all grades occurs in more than 90% of patients. However, there are few reports of purpura induced by anti-epidermal growth factor receptor antibody.
View Article and Find Full Text PDFSurg Case Rep
December 2018
Department of Gastrointestinal and General Surgery, Koga General Hospital, Miyazaki, Japan.
Background: IgG4-related disease (IgG4-RD) is a pathological condition that is characterized by an infiltrate composed of IgG4-positive plasma cells and recently recognized as an immune-mediated condition. It causes tissue throughout the body to become stiff and thickened due to autoimmune reactions that cause fibrosis and scarring. Disease-related changes commonly occur in the salivary glands, bile duct, pancreas, and lungs, but are seldom seen in the small bowel.
View Article and Find Full Text PDFJ Hosp Palliat Nurs
April 2019
Yusuke Kanno, PhD, RN, is project researcher, Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Miyagi; and Division of Psycho-Oncology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan. Kazuki Sato, PhD, RN, is associate professor, Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Miyagi; and Department of Nursing, Nagoya University Graduate School of Medicine, Aichi, Japan. Megumi Shimizu, PhD, RN, is assistant professor, Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine; and Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Miyagi, Japan. Yuko Funamizu, RN, is clinical nurse, Department of Palliative Care Team, Nakadori General Hospital, Akita, Japan. Hideaki Andoh, MD, PhD, is professor, Department of Clinical Nursing, Akita University Graduate School of Health Science, Japan. Megumi Kishino, RN, is clinical nurse, Department of Palliative Care Unit, Shimura Hospital, Hiroshima; and Department of Nursing/Palliative Care Team, Kobe University Hospital, Hyogo, Japan. Tomomi Senaga, RN, is clinical nurse, Department of Palliative Care Unit, Adventist Medical Center, Okinawa, Japan. Tetsu Takahashi, MD, is clinical doctor, Department of Surgery, Koga General Hospital, Miyazaki; and Yushokai Home Medical Care Clinic, Kitasenju, Japan. Mitsunori Miyashita, PhD, RN, is professor, Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Miyagi, Japan.
This study develops and examines the validity and reliability of 2 scales, respectively, for evaluating nursing care and the experience of difficulties providing nursing care for dying patients with cancer and their families. A cross-sectional anonymous questionnaire was administered to nursing staff caring for dying patients with cancer and their families in 4 general hospitals and a university hospital in Japan. The instruments assessed were the Nursing Care Scale for Dying Patients and Their Families (NCD) and the Nurse's Difficulty Scale for Dying Patients and Their Families (NDD).
View Article and Find Full Text PDFInt J Hematol
October 2018
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
A new entity, namely early/prefibrotic primary myelofibrosis (PMF), was introduced as a subtype of PMF in the 2016 revised World Health Organization (WHO) criteria for myeloproliferative neoplasms (MPN). It was diagnosed based on histopathological features of bone marrow (BM) biopsy specimens together with clinical parameters [leukocytosis, anemia, elevated lactate dehydrogenase (LDH) values, and splenomegaly]. The aim of this study was to evaluate the prevalence of early/prefibrotic PMF in patients who were previously diagnosed with ET, and to compare clinical features at diagnosis and outcomes between early/prefibrotic PMF and essential thrombocythemia (ET) patients.
View Article and Find Full Text PDFAm J Hosp Palliat Care
February 2019
1 Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Objective:: There are no instruments evaluating the processes and outcomes of dying care right before and after death. Therefore, we developed and examined the validity and reliability of 2 scales for evaluating dying care processes and outcomes before and after death.
Methods:: A cross-sectional, anonymous questionnaire was administered to bereaved family members of patients with cancer who had died in 5 facilities.
Nihon Hoshasen Gijutsu Gakkai Zasshi
March 2019
Department of Pathology, Faculty of Medicine, University of Miyazaki.
Int J Hematol
June 2018
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Polycythemia vera (PV) and essential thrombocythemia (ET) are associated with life-threatening thrombohemorrhagic events, and disease progression and development of non-hematological malignancies also reduce long-term survival. We retrospectively surveyed thrombohemorrhagic events and overall survival (OS) in 62 PV and 117 ET patients. The cumulative incidences of thrombohemorrhagic events in PV and ET patients were 11.
View Article and Find Full Text PDFWorld J Hepatol
December 2017
Department of Gastoroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1601, Japan.
Aim: To evaluate the efficacy and safety of a regimen containing sofosbuvir (SOF) and ledipasvir (LDV) in Japanese patients aged ≥ 75 years with hepatitis C genotype 1.
Methods: This multicenter, retrospective study consisted of 246 Japanese patients with HCV genotype 1 at nine centers in Miyazaki prefecture in Japan. Demographic, clinical, virological, and adverse effects (AE)-related data obtained during and after SOF/LDV therapy were collected from medical records.
Intern Med
September 2017
Department of Surgery, Koga General Hospital, Japan.
A 69-year-old woman was admitted to our hospital with the chief complaints of fever and fatigue. We initially treated the patient for a tick-borne disease after noticing a pustule on her leg; however, abdominal computed tomography (CT) showed multiple low-density areas in the liver and Chromobacterium violaceum was isolated from a blood culture. We diagnosed her with multiple liver abscesses secondary to Chromobacterium violaceum bacteremia.
View Article and Find Full Text PDFAppl Radiat Isot
October 2017
Nuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Tokai, Ibaraki 319-1195, Japan.
We assessed the accuracy of mono-energetic electron and beta-emitting isotope dose-point kernels (DPKs) calculated using the particle and heavy ion transport code system (PHITS) for patient-specific dosimetry in targeted radionuclide treatment (TRT) and compared our data with published data. All mono-energetic and beta-emitting isotope DPKs calculated using PHITS, both in water and compact bone, were in good agreement with those in literature using other MC codes. PHITS provided reliable mono-energetic electron and beta-emitting isotope scaled DPKs for patient-specific dosimetry.
View Article and Find Full Text PDFIntern Med
May 2017
Department of Internal Medicine, Koga General Hospital, Japan.
Circ J
October 2017
Department of Internal Medicine, Koga General Hospital.